indocyanine green has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cao, W; Cui, D; Hou, N; Li, W; Liu, B; Liu, Y; Tan, H; Wang, Z; Xu, B; Zheng, D | 1 |
1 other study(ies) available for indocyanine green and Prostatic Neoplasms, Castration-Resistant
Article | Year |
---|---|
CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer.
Topics: AC133 Antigen; Animals; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Gold; Heterografts; Humans; Indocyanine Green; Male; Mice; Molecular Targeted Therapy; Multimodal Imaging; Nanoparticles; Photochemotherapy; Photothermal Therapy; Prostatic Neoplasms, Castration-Resistant | 2020 |